2006
DOI: 10.1074/jbc.m510096200
|View full text |Cite
|
Sign up to set email alerts
|

Substrate Specificity of Human Kallikrein 6

Abstract: Human kallikrein 6 (hK6) is abundantly expressed in the central nervous system and is implicated in demyelinating disease. This study provided biochemical data about the substrate specificity and activation of hK6 by glycosaminoglycans and by kosmotropic salts, which followed the Hofmeister series. The screening of fluorescence resonance energy transfer (FRET) peptide families derived from Abz-KLRSSKQ-EDDnp resulted in the finding that Abz-AFRFSQ-EDDnp (where Abz is ortho-aminobenzoic acid and EDDnp is N-[2,4-… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
41
1
1

Year Published

2006
2006
2022
2022

Publication Types

Select...
10

Relationship

5
5

Authors

Journals

citations
Cited by 90 publications
(45 citation statements)
references
References 74 publications
2
41
1
1
Order By: Relevance
“…However, the actions of hK5 and -6 were distinct from those of hK14 in terms of their inability to activate PAR 4 . The lack of activation of PAR 4 by these two kallikreins is in keeping with the very minor cleavage by hK5 and -6 we observed by HPLC analysis for the PAR 4 -derived peptides and the lack of hydrolysis by hK6 of a model PAR 4 peptide described in work that appeared after completion of our study (56). We therefore anticipate that the other human kallikreins apart from hK5, -6, and -14 as well as kallikreins from other species will have both common and distinct actions via the different PARs.…”
Section: Discussionsupporting
confidence: 49%
“…However, the actions of hK5 and -6 were distinct from those of hK14 in terms of their inability to activate PAR 4 . The lack of activation of PAR 4 by these two kallikreins is in keeping with the very minor cleavage by hK5 and -6 we observed by HPLC analysis for the PAR 4 -derived peptides and the lack of hydrolysis by hK6 of a model PAR 4 peptide described in work that appeared after completion of our study (56). We therefore anticipate that the other human kallikreins apart from hK5, -6, and -14 as well as kallikreins from other species will have both common and distinct actions via the different PARs.…”
Section: Discussionsupporting
confidence: 49%
“…The hydrolysis of pro-KLK5 and -10 exhibits the greatest increase in response to acidic conditions (Tables 2 and 3), and because these KLKs are co-expressed with KLK6 in the CNS, we postulate that this response is of physiological relevance. The buffer conditions utilized in this study are unlikely to be optimal in each case, as studies have shown that salts and pH can have a substantial influence upon individual KLK activity and indeed may serve to regulate their activity (15,62).…”
Section: Discussionmentioning
confidence: 99%
“…Deacetylase assays were performed at 37°C in 50 l of 25 mM Tris-HCl (pH 8.0), 137 mM NaCl, 2.7 mM KCl, 1 mM MgCl 2 containing 0.6 mM NAD ϩ (Sigma-Aldrich), and 20 M synthetic peptide Abz-Gly-Proacetyl-Lys-Ser-Gln-EDDnp, where Abz is ortho-aminobenzoic acid and EDDnp is N- [2,4-dinitrophenyl]ethylenediamine. The peptide was synthesized as described previously (31), further purified by chromatography on a C 18 column, dried, and resuspended in DMSO. A recombinant protein corresponding to the T. brucei RNA triphosphatase cloned in pET28a (32) was prepared similarly and used as a negative control, and a total HeLa cell extract was used as a positive control in the activity assays.…”
Section: Methodsmentioning
confidence: 99%